BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34914257)

  • 1. [Composition and histopathological features of prostatic calculi in patients with benign prostatic hyperplasia].
    Jin YS; Dong B; Jia JQ; Wang F; He XL; Gao JX; Li Y
    Zhonghua Nan Ke Xue; 2021 Sep; 27(9):809-814. PubMed ID: 34914257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparative study of thulium laser resection of the prostate and bipolar transurethral plasmakinetic prostatectomy for treating benign prostatic hyperplasia.
    Peng B; Wang GC; Zheng JH; Xia SQ; Geng J; Che JP; Yan Y; Huang JH; Xu YF; Yang B
    BJU Int; 2013 Apr; 111(4):633-7. PubMed ID: 23107074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lower urinary tract symptoms in benign prostatic hyperplasia patients: orchestrated by chronic prostatic inflammation and prostatic calculi?
    Kim SH; Jung KI; Koh JS; Min KO; Cho SY; Kim HW
    Urol Int; 2013; 90(2):144-9. PubMed ID: 23295780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bipolar plasma enucleation of the prostate vs open prostatectomy in large benign prostatic hyperplasia cases - a medium term, prospective, randomized comparison.
    Geavlete B; Stanescu F; Iacoboaie C; Geavlete P
    BJU Int; 2013 May; 111(5):793-803. PubMed ID: 23469933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Safety and effect of transurethral holmium laser enucleation of the prostate versus bipolar transurethral plasmakinetic prostatectomy for benign prostatic hyperplasia: A meta-analysis].
    Guo Q; Xiao Y; Li JW; Zhang JD; Zhang YG
    Zhonghua Nan Ke Xue; 2016 Oct; 22(10):914-922. PubMed ID: 29278474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results of the CombAT study.
    Roehrborn CG; Barkin J; Tubaro A; Emberton M; Wilson TH; Brotherton BJ; Castro R
    BJU Int; 2014 Apr; 113(4):623-35. PubMed ID: 24127818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of total prostate volume and transitional zone volume on the curative effect of transurethral resection of prostate in benign prostatic hyperplasia].
    Liu HM; Tian Y; Su ZY; Sun ZL; Luo GH
    Zhonghua Yi Xue Za Zhi; 2021 Jan; 101(2):137-141. PubMed ID: 33455130
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy and Safety Evaluation of Transurethral Resection of the Prostate versus Plasmakinetic Enucleation of the Prostate in the Treatment of Massive Benign Prostatic Hyperplasia.
    Zhang J; Wang Y; Li S; Jin S; Zhang S; Zhao C; Yang W; Cui S; Liu Y
    Urol Int; 2021; 105(9-10):735-742. PubMed ID: 33524981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential role of glutathione S-transferase P1 gene polymorphism and metabolic syndrome in lower urinary tract symptoms attributed to benign prostatic hyperplasia.
    Zhang W; Li Z; Liu M; Mu Y; He J; Chen P; Liu D; Chen K; Che B; Xu S; Zhang H; Tang K
    World J Urol; 2021 Dec; 39(12):4413-4419. PubMed ID: 34228163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for bladder calculi in patients with benign prostatic hyperplasia.
    Huang W; Cao JJ; Cao M; Wu HS; Yang YY; Xu ZM; Jin XD
    Medicine (Baltimore); 2017 Aug; 96(32):e7728. PubMed ID: 28796057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical application of combination suprapubic prostatectomy with transurethral resection of the prostate (TURP) in patients with large volume benign prostatic hyperplasia (BPH).
    Wei S; Cheng F; Yu W
    Urologia; 2020 May; 87(2):65-69. PubMed ID: 30868937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expressions of interleukin-17 and interleukin-8 in the prostatic tissue of the patients with BPH or BPH with inflammation].
    Gao R; Liu QX; Zhou HL; Cao LS; Jiang T; Tang SX; Ding YL
    Zhonghua Nan Ke Xue; 2017 Aug; 23(8):697-702. PubMed ID: 29726643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adding Cyclooxygenase-2 inhibitor to alpha blocker for patients with benign prostate hyperplasia and elevated serum prostate specific antigen could not improve prostate biopsy detection rate but improve lower urinary tract symptoms.
    Jhang JF; Jiang YH; Kuo HC
    Int J Clin Pract; 2013 Dec; 67(12):1327-33. PubMed ID: 24246211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feasibility of holmium laser enucleation of the prostate (HoLEP) for recurrent/residual benign prostatic hyperplasia (BPH).
    Elshal AM; Elmansy HM; Elhilali MM
    BJU Int; 2012 Dec; 110(11 Pt C):E845-50. PubMed ID: 22702908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Calcium Oxalate on Expression of Clusterin and Lower Urinary Tract Symptoms in Prostatitis and Benign Prostatic Hyperplasia Patients with Calculi.
    Sun C; Xie G; Huang F; Liu X
    Med Sci Monit; 2018 Dec; 24():9196-9203. PubMed ID: 30560838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Risk factors for postoperative long-term hematuria in patients with benign prostatic hyperplasia].
    Luo WP; Zhao Y; Huang X; Nie J
    Zhonghua Nan Ke Xue; 2022 May; 28(5):422-426. PubMed ID: 37477481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between a transurethral prostate split and transurethral prostate resection for benign prostatic hyperplasia treatment in a small prostate volume: a prospective controlled study.
    Wang B; Zhang S; Sun C; Du C; He G; Wen J
    Ann Transl Med; 2020 Aug; 8(16):1016. PubMed ID: 32953816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlation between TCM syndrome types and clinical symptoms of benign prostatic hyperplasia with chronic prostatitis].
    Huang XF; Ning KQ; Wang Q; Liu T; He Y; Xue JG; Dai LQ; Zhu YK
    Zhonghua Nan Ke Xue; 2017 Dec; 23(12):1111-1115. PubMed ID: 29738184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostatic arterial embolization for the treatment of lower urinary tract symptoms caused by benign prostatic hyperplasia: a comparative study of medium- and large-volume prostates.
    Wang M; Guo L; Duan F; Yuan K; Zhang G; Li K; Yan J; Wang Y; Kang H
    BJU Int; 2016 Jan; 117(1):155-64. PubMed ID: 25851432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between benign prostatic hyperplasia/lower urinary tract symptoms and total serum testosterone level in healthy middle-aged eugonadal men.
    Lee JH; Kim Y; Park YW; Lee DG
    J Sex Med; 2014 May; 11(5):1309-15. PubMed ID: 24612680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.